Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,888 | 5,496 | 4,954 | 4,707 | 3,478 |
| Operating Income | -4,888 | -5,496 | -4,954 | -4,707 | -3,478 |
| Interest Expense | 13 | 0 | 0 | 0 | 0 |
| Other Income | 84 | 361 | 664 | 36 | 7 |
| Pre-tax Income | -4,817 | -5,134 | -4,290 | -4,671 | -3,470 |
| Net Income Continuous | -4,817 | -5,134 | -4,290 | -4,671 | -3,470 |
| Net Income | $-4,817 | $-5,134 | $-4,290 | $-4,671 | $-3,470 |
| EPS Basic Total Ops | -239,500.40 | -490,325.30 | -244,427.80 | -266,245.10 | -0.27 |
| EPS Basic Continuous Ops | -239,502.70 | -490,319.00 | -244,463.80 | -266,212.40 | -0.27 |
| EPS Diluted Total Ops | -239,500.40 | -490,325.30 | -244,427.80 | -266,245.10 | -0.27 |
| EPS Diluted Continuous Ops | -239,502.70 | -490,319.00 | -244,463.80 | -266,212.40 | -0.27 |
| EBITDA(a) | $-4,788 | $-5,466 | $-4,929 | $-4,685 | $-3,456 |